Celia Goulding
We are deciphering iron acquisition in Mycobacterium tuberculosis informed by structural and chemical biology, and proteomics. We are also working […]
Paul Gershon
Mechanistic and structural characterization of vaccinia viral proteins, with an emphasis on specific mRNA synthetic and modification enzymes, using mass
E. R. Chulie Ulloa
We investigate novel therapeutic strategies (e.g., immune-based therapies and drug-repurposing) to treat drug-tolerant or -resistant bacterial pathogens.
Melissa Lodoen
My research program is focused on the innate immunity, neuroinflammation, and host-pathogen interactions during infection with Toxoplasma gondii.
Don Forthal
My laboratory focuses on understanding how antibodies interact with cells bearing Fc receptors (such as macrophages, monocytes, NK cells) and
Philip L. Felgner
The UCI Vaccine R&D Center is supported by the NIH to develop vaccine and vaccine adjuvants for infectious diseases. There
Elizabeth N. Bess
Uncovering chemical reactions encoded in the gut microbiome to understand and treat human disease